Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) last released its earnings results on Thursday, May 14th. On average, analysts expect Jasper Therapeutics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year. Get Jasper Therapeutics alerts:Jasper Therapeutics Stock PerformanceShares of JSPR stock opened at $0.67 on Wednesday. Jasper Therapeutics has a fifty-two week low of $0.32 and a fifty-two week high of $3.14. Further ReadingReceive News & Ratings for Jasper Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jasper Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.